(This is a contributed guest column. To be considered as an MJBizDaily guest columnist, please submit your request here.)
As federal marijuana rescheduling inches closer to reality, operators must confront a fundamental shift in how legal cannabis businesses will be regulated.
Downgrading cannabis to Schedule 3 of the Controlled Substances Act signals a transition toward a federal medical model of cannabis. With that comes heightened enforcement around cybersecurity, data privacy, and compliance – requirements that many operators are not yet prepared to meet.
ADVERTISEMENT
Medical models attract pharmaceutical investment. They also mean patients whose data is among the most highly protected in the United States.
That combination dramatically raises the stakes for cannabis businesses that collect, store, or process data — be it
Read full article on Marijuana Business Daily
